Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting-Reference-Cited by-同舟云学术

Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting

Published:2022-05 Issue:3 Volume:74 Page:245-248
ISSN:0019-4832
Container-title:Indian Heart Journal
language:en
Short-container-title:Indian Heart Journal

Author:

Anand Aishwarya,Kumar Rupesh,Gupta Ankur,Vijayvergiya Rajesh,Mehrotra Saurabh,Lad Deepesh,Barwad Parag,Sharma Swati,Patil Amol N.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. New oral anticoagulants for atrial fibrillation;Shafeeq;Pharm Ther,2014

2. Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association/American stroke association;Kleindorfer;Stroke,2021

3. Quality of anticoagulation with warfarin in rural Chhattisgarh, India;Chebrolu;Indian J Med Res,2020

4. Genetic and nongenetic determinants of variable warfarin dose requirements: a report from North India;Kaur;Public Health Genomics,2021

5. Warfarin initiation nomograms for venous thromboembolism;Garcia;Cochrane Database Syst Rev,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial;Annals of Hematology;2024-04-18

2. Integrated analysis of clinical and genetic factors on the interindividual variation of warfarin anticoagulation efficacy in clinical practice;BMC Cardiovascular Disorders;2023-05-31

3. Development and validation wise assessment of genotype guided warfarin dosing algorithm in Indian population;Drug Metabolism and Personalized Therapy;2023-04-19